close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Leslie Popplewell

location-icon

Atlanta, GA

LOCATION OF PRACTICE
City Of Hope
MEDICAL Specialty:

Non-hodgkin Lymphoma



NPI Number
1457310450
ABOUT

Leslie Popplewell, MD is the Hematology and Blood and Marrow Transplant Medical Director for the City of Hope Cancer Center. Dr. Popplewell primarily treats patients with hematologic malignancies, especially lymphoma.

Dr. Leslie Popplewell profile image

Published Articles

Examining the role of the environment in facilitating the development of self-regulated learning skills in high-performance female academy youth footballers.- 2026 Jun 16
High Incidence of Cytomegalovirus Infection in Patients Receiving Standard of Care CD19- or BCMA-Targeted CAR-T Cell Therapies for Hematologic Malignancies.- 2026 May 19
Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma.- 2026 Jun
Dystrophin Restorative and Compensatory Gene Addition Therapies for Duchenne Muscular Dystrophy: Could CRISPRa Provide a Realistic Alternative?- 2025 Nov 10
Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study.- 2026 Jan
Real-world experience with CAR-T therapy in relapsed and refractory follicular lymphoma.- 2025 Oct
Safety and efficacy of the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial.- 2026 Jan 1
Evaluating the Role of CAR-T Cell Therapy in the Context of Current Therapy Options for Patients With Relapsed or Refractory Follicular Lymphoma.- 2025 Sep
Periostin Exon 17 Skipping Enhances the Efficacy of Local Adeno-Associated Viral-Microdystrophin Administration in a Fibrotic Model of Duchenne Muscular Dystrophy.- 2025 Sep
Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry.- 2025 Feb 9

Clinical Trials

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
CAR-T Long Term Follow Up (LTFU) Study
Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Other Specialists treating Non-Hodgkin Lymphoma in Atlanta, GA

See All Doctors

Dr. Trailokya Pandit

Specialty: Hematology Oncology

My Resources
location-icon

Piedmont Cancer Institute

My Resources

Dr. Jonathon Cohen

Specialty: Hematology Oncology

My Resources
location-icon

Emory Winship Cancer Institute

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider